Systemic lupus erythematosus: one year in review 2023.

Humans Lupus Erythematosus, Systemic / diagnosis Autoimmune Diseases Comorbidity Biomarkers / metabolism

Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
May 2023
Historique:
received: 27 02 2023
accepted: 13 03 2023
medline: 5 5 2023
pubmed: 3 5 2023
entrez: 3 5 2023
Statut: ppublish

Résumé

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations and a relapsing-remitting course. New data regarding pathogenic pathways, biomarkers and clinical manifestations of SLE are emerging, and new drugs and therapeutic protocols have been proposed to improve the control of disease activity. Furthermore, new insights into comorbidities and reproductive health in SLE patients are constantly emerging.This annual review aims to summarise the most relevant data on SLE that was published in 2022.

Identifiants

DOI: 10.55563/clinexprheumatol/4uc7e8 PMID: 37133502
pubmed: 37133502
pii: 19703
doi: 10.55563/clinexprheumatol/4uc7e8
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

997-1008

Auteurs

Dina Zucchi (D)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy. dinazucchi@hotmail.it.

Ettore Silvagni (E)

Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy.

Elena Elefante (E)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Viola Signorini (V)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Chiara Cardelli (C)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.

Francesca Trentin (F)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Davide Schilirò (D)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Giancarlo Cascarano (G)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Anastasiya Valevich (A)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Alessandra Bortoluzzi (A)

Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy.

Chiara Tani (C)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Systemic lupus erythematosus: one year in review 2023.
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Lupus érythémateux disséminé › Systemic lupus erythematosus: one year in review 2023.
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Systemic lupus erythematosus: one year in review 2023.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Comorbidité › Systemic lupus erythematosus: one year in review 2023.
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Systemic lupus erythematosus: one year in review 2023.